Clq metabolism in ulcerative colitis and Crohn's disease.
Open Access
- 31 October 1979
- Vol. 20 (11), 1012-1019
- https://doi.org/10.1136/gut.20.11.1012
Abstract
The metabolism of pure radioiodine labelled Clq has been observed in five patients with ulcerative colitis, five patients with Crohn's disease, and in five control subjects. Both the fractional catabolic rate and the synthesis rate of Clq were increased in the five patients with Crohn's disease and in four of the five patients with ulcerative colitis. The fifth patient was in remission and had a normal synthesis rate. These results support the hypothesis that complement activation plays a role in the pathogenesis of these disease states and that the increased complement activation is primarily via the classical pathway.This publication has 22 references indexed in Scilit:
- Humoral immune system in inflammatory bowel disease: I. Complement levels.Gut, 1977
- Inhibition of complement‐dependent lymphocyte rosette formation: a possible test for activated complement productsEuropean Journal of Immunology, 1974
- EVIDENCE FOR COMPLEMENT-BINDING IMMUNE COMPLEXES IN ADULT CŒLIAC DISEASE, CROHN'S DISEASE, AND ULCERATIVE COLITISThe Lancet, 1973
- CIRCULATING IMMUNE COMPLEXES IN DERMATITIS HERPETIFORMISThe Lancet, 1973
- Analysis of Disappearance Time‐Curves After Single Injection of Labelled ProteinsPublished by Wiley ,1973
- ANTIBACTERIAL ANTIBODIES IN RECTAL AND COLONIC MUCOSA IN ULCERATIVE COLITISThe Lancet, 1971
- A Method of Trace Iodination of Proteins for Immunologic StudiesInternational Archives of Allergy and Immunology, 1966
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- The Theory of Tracer Experiments with 131I-Labelled Plasma ProteinsPhysics in Medicine & Biology, 1957
- Cortisone in Ulcerative ColitisBMJ, 1955